img

Global Tourette Syndrome Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Tourette Syndrome Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Tourette Syndrome Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Tourette Syndrome Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Research Center and Hospital are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Tourette Syndrome Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Tourette Syndrome Drug key manufacturers include Abide Therapeutics Inc, Catalyst Pharmaceuticals Inc, Neurocrine Biosciences Inc, Psyadon Pharmaceuticals Inc, Reviva Pharmaceuticals Inc, Synchroneuron Inc, Teva Pharmaceutical Industries Ltd and Therapix Biosciences Ltd, etc. Abide Therapeutics Inc, Catalyst Pharmaceuticals Inc, Neurocrine Biosciences Inc are top 3 players and held % sales share in total in 2022.
Tourette Syndrome Drug can be divided into AZD-5213, CPP-115, Dutetrabenazine ER and Ecopipam Hydrochloride, etc. AZD-5213 is the mainstream product in the market, accounting for % sales share globally in 2022.
Tourette Syndrome Drug is widely used in various fields, such as Research Center, Hospital, Clinic and Others, etc. Research Center provides greatest supports to the Tourette Syndrome Drug industry development. In 2022, global % sales of Tourette Syndrome Drug went into Research Center filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Tourette Syndrome Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Abide Therapeutics Inc
Catalyst Pharmaceuticals Inc
Neurocrine Biosciences Inc
Psyadon Pharmaceuticals Inc
Reviva Pharmaceuticals Inc
Synchroneuron Inc
Teva Pharmaceutical Industries Ltd
Therapix Biosciences Ltd
Segment by Type
AZD-5213
CPP-115
Dutetrabenazine ER
Ecopipam Hydrochloride
Others

Segment by Application


Research Center
Hospital
Clinic
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Tourette Syndrome Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Tourette Syndrome Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Tourette Syndrome Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Tourette Syndrome Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Tourette Syndrome Drug introduction, etc. Tourette Syndrome Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Tourette Syndrome Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Tourette Syndrome Drug Market Overview
1.1 Tourette Syndrome Drug Product Overview
1.2 Tourette Syndrome Drug Market Segment by Type
1.2.1 AZD-5213
1.2.2 CPP-115
1.2.3 Dutetrabenazine ER
1.2.4 Ecopipam Hydrochloride
1.2.5 Others
1.3 Global Tourette Syndrome Drug Market Size by Type
1.3.1 Global Tourette Syndrome Drug Market Size Overview by Type (2018-2034)
1.3.2 Global Tourette Syndrome Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Tourette Syndrome Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Tourette Syndrome Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Tourette Syndrome Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Tourette Syndrome Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Tourette Syndrome Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Tourette Syndrome Drug Sales Breakdown by Type (2018-2024)
2 Global Tourette Syndrome Drug Market Competition by Company
2.1 Global Top Players by Tourette Syndrome Drug Sales (2018-2024)
2.2 Global Top Players by Tourette Syndrome Drug Revenue (2018-2024)
2.3 Global Top Players by Tourette Syndrome Drug Price (2018-2024)
2.4 Global Top Manufacturers Tourette Syndrome Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Tourette Syndrome Drug Market Competitive Situation and Trends
2.5.1 Tourette Syndrome Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Tourette Syndrome Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tourette Syndrome Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Tourette Syndrome Drug Market
2.8 Key Manufacturers Tourette Syndrome Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Tourette Syndrome Drug Status and Outlook by Region
3.1 Global Tourette Syndrome Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Tourette Syndrome Drug Historic Market Size by Region
3.2.1 Global Tourette Syndrome Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Tourette Syndrome Drug Sales in Value by Region (2018-2024)
3.2.3 Global Tourette Syndrome Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Tourette Syndrome Drug Forecasted Market Size by Region
3.3.1 Global Tourette Syndrome Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Tourette Syndrome Drug Sales in Value by Region (2024-2034)
3.3.3 Global Tourette Syndrome Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Tourette Syndrome Drug by Application
4.1 Tourette Syndrome Drug Market Segment by Application
4.1.1 Research Center
4.1.2 Hospital
4.1.3 Clinic
4.1.4 Others
4.2 Global Tourette Syndrome Drug Market Size by Application
4.2.1 Global Tourette Syndrome Drug Market Size Overview by Application (2018-2034)
4.2.2 Global Tourette Syndrome Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Tourette Syndrome Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Tourette Syndrome Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Tourette Syndrome Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Tourette Syndrome Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Tourette Syndrome Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Tourette Syndrome Drug Sales Breakdown by Application (2018-2024)
5 North America Tourette Syndrome Drug by Country
5.1 North America Tourette Syndrome Drug Historic Market Size by Country
5.1.1 North America Tourette Syndrome Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Tourette Syndrome Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Tourette Syndrome Drug Sales in Value by Country (2018-2024)
5.2 North America Tourette Syndrome Drug Forecasted Market Size by Country
5.2.1 North America Tourette Syndrome Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Tourette Syndrome Drug Sales in Value by Country (2024-2034)
6 Europe Tourette Syndrome Drug by Country
6.1 Europe Tourette Syndrome Drug Historic Market Size by Country
6.1.1 Europe Tourette Syndrome Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Tourette Syndrome Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Tourette Syndrome Drug Sales in Value by Country (2018-2024)
6.2 Europe Tourette Syndrome Drug Forecasted Market Size by Country
6.2.1 Europe Tourette Syndrome Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Tourette Syndrome Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Tourette Syndrome Drug by Region
7.1 Asia-Pacific Tourette Syndrome Drug Historic Market Size by Region
7.1.1 Asia-Pacific Tourette Syndrome Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Tourette Syndrome Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Tourette Syndrome Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Tourette Syndrome Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Tourette Syndrome Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Tourette Syndrome Drug Sales in Value by Region (2024-2034)
8 Latin America Tourette Syndrome Drug by Country
8.1 Latin America Tourette Syndrome Drug Historic Market Size by Country
8.1.1 Latin America Tourette Syndrome Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Tourette Syndrome Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Tourette Syndrome Drug Sales in Value by Country (2018-2024)
8.2 Latin America Tourette Syndrome Drug Forecasted Market Size by Country
8.2.1 Latin America Tourette Syndrome Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Tourette Syndrome Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Tourette Syndrome Drug by Country
9.1 Middle East and Africa Tourette Syndrome Drug Historic Market Size by Country
9.1.1 Middle East and Africa Tourette Syndrome Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Tourette Syndrome Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Tourette Syndrome Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Tourette Syndrome Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Tourette Syndrome Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Tourette Syndrome Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Abide Therapeutics Inc
10.1.1 Abide Therapeutics Inc Company Information
10.1.2 Abide Therapeutics Inc Introduction and Business Overview
10.1.3 Abide Therapeutics Inc Tourette Syndrome Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Abide Therapeutics Inc Tourette Syndrome Drug Products Offered
10.1.5 Abide Therapeutics Inc Recent Development
10.2 Catalyst Pharmaceuticals Inc
10.2.1 Catalyst Pharmaceuticals Inc Company Information
10.2.2 Catalyst Pharmaceuticals Inc Introduction and Business Overview
10.2.3 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Products Offered
10.2.5 Catalyst Pharmaceuticals Inc Recent Development
10.3 Neurocrine Biosciences Inc
10.3.1 Neurocrine Biosciences Inc Company Information
10.3.2 Neurocrine Biosciences Inc Introduction and Business Overview
10.3.3 Neurocrine Biosciences Inc Tourette Syndrome Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Neurocrine Biosciences Inc Tourette Syndrome Drug Products Offered
10.3.5 Neurocrine Biosciences Inc Recent Development
10.4 Psyadon Pharmaceuticals Inc
10.4.1 Psyadon Pharmaceuticals Inc Company Information
10.4.2 Psyadon Pharmaceuticals Inc Introduction and Business Overview
10.4.3 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Products Offered
10.4.5 Psyadon Pharmaceuticals Inc Recent Development
10.5 Reviva Pharmaceuticals Inc
10.5.1 Reviva Pharmaceuticals Inc Company Information
10.5.2 Reviva Pharmaceuticals Inc Introduction and Business Overview
10.5.3 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Products Offered
10.5.5 Reviva Pharmaceuticals Inc Recent Development
10.6 Synchroneuron Inc
10.6.1 Synchroneuron Inc Company Information
10.6.2 Synchroneuron Inc Introduction and Business Overview
10.6.3 Synchroneuron Inc Tourette Syndrome Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Synchroneuron Inc Tourette Syndrome Drug Products Offered
10.6.5 Synchroneuron Inc Recent Development
10.7 Teva Pharmaceutical Industries Ltd
10.7.1 Teva Pharmaceutical Industries Ltd Company Information
10.7.2 Teva Pharmaceutical Industries Ltd Introduction and Business Overview
10.7.3 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Products Offered
10.7.5 Teva Pharmaceutical Industries Ltd Recent Development
10.8 Therapix Biosciences Ltd
10.8.1 Therapix Biosciences Ltd Company Information
10.8.2 Therapix Biosciences Ltd Introduction and Business Overview
10.8.3 Therapix Biosciences Ltd Tourette Syndrome Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Therapix Biosciences Ltd Tourette Syndrome Drug Products Offered
10.8.5 Therapix Biosciences Ltd Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Tourette Syndrome Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Tourette Syndrome Drug Industrial Chain Analysis
11.4 Tourette Syndrome Drug Market Dynamics
11.4.1 Tourette Syndrome Drug Industry Trends
11.4.2 Tourette Syndrome Drug Market Drivers
11.4.3 Tourette Syndrome Drug Market Challenges
11.4.4 Tourette Syndrome Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Tourette Syndrome Drug Distributors
12.3 Tourette Syndrome Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of AZD-5213
Table 2. Major Company of CPP-115
Table 3. Major Company of Dutetrabenazine ER
Table 4. Major Company of Ecopipam Hydrochloride
Table 5. Major Company of Others
Table 6. Global Tourette Syndrome Drug Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Tourette Syndrome Drug Sales by Type (2018-2024) & (K Pcs)
Table 8. Global Tourette Syndrome Drug Sales Market Share in Volume by Type (2018-2024)
Table 9. Global Tourette Syndrome Drug Sales by Type (2018-2024) & (US& Million)
Table 10. Global Tourette Syndrome Drug Market Share in Value by Type (2018-2024)
Table 11. Global Tourette Syndrome Drug Price by Type (2018-2024) & (USD/Pcs)
Table 12. Global Tourette Syndrome Drug Sales by Type (2024-2034) & (K Pcs)
Table 13. Global Tourette Syndrome Drug Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Tourette Syndrome Drug Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Tourette Syndrome Drug Sales Market Share in Value by Type (2024-2034)
Table 16. Global Tourette Syndrome Drug Price by Type (2024-2034) & (USD/Pcs)
Table 17. North America Tourette Syndrome Drug Sales by Type (2018-2024) & (K Pcs)
Table 18. North America Tourette Syndrome Drug Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe Tourette Syndrome Drug Sales (K Pcs) by Type (2018-2024)
Table 20. Europe Tourette Syndrome Drug Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific Tourette Syndrome Drug Sales (K Pcs) by Type (2018-2024)
Table 22. Asia-Pacific Tourette Syndrome Drug Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America Tourette Syndrome Drug Sales (K Pcs) by Type (2018-2024)
Table 24. Latin America Tourette Syndrome Drug Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa Tourette Syndrome Drug Sales (K Pcs) by Type (2018-2024)
Table 26. Middle East and Africa Tourette Syndrome Drug Sales by Type (2018-2024) & (US$ Million)
Table 27. Global Tourette Syndrome Drug Sales by Company (2018-2024) & (K Pcs)
Table 28. Global Tourette Syndrome Drug Sales Share by Company (2018-2024)
Table 29. Global Tourette Syndrome Drug Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global Tourette Syndrome Drug Revenue Share by Company (2018-2024)
Table 31. Global Market Tourette Syndrome Drug Price by Company (2018-2024) & (USD/Pcs)
Table 32. Global Tourette Syndrome Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Tourette Syndrome Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tourette Syndrome Drug as of 2022)
Table 35. Date of Key Manufacturers Enter into Tourette Syndrome Drug Market
Table 36. Key Manufacturers Tourette Syndrome Drug Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Tourette Syndrome Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 39. Global Tourette Syndrome Drug Sales by Region (2018-2024) & (K Pcs)
Table 40. Global Tourette Syndrome Drug Sales Market Share in Volume by Region (2018-2024)
Table 41. Global Tourette Syndrome Drug Sales by Region (2018-2024) & (US$ Million)
Table 42. Global Tourette Syndrome Drug Sales Market Share in Value by Region (2018-2024)
Table 43. Global Tourette Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 44. Global Tourette Syndrome Drug Sales by Region (2024-2034) & (K Pcs)
Table 45. Global Tourette Syndrome Drug Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Tourette Syndrome Drug Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Tourette Syndrome Drug Sales Market Share in Value by Region (2024-2034)
Table 48. Global Tourette Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 49. Global Tourette Syndrome Drug Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 50. Global Tourette Syndrome Drug Sales by Application (2018-2024) & (K Pcs)
Table 51. Global Tourette Syndrome Drug Sales Market Share in Volume by Application (2018-2024)
Table 52. Global Tourette Syndrome Drug Sales by Application (2018-2024) & (US$ Million)
Table 53. Global Tourette Syndrome Drug Sales Market Share in Value by Application (2018-2024)
Table 54. Global Tourette Syndrome Drug Price by Application (2018-2024) & (USD/Pcs)
Table 55. Global Tourette Syndrome Drug Sales by Application (2024-2034) & (K Pcs)
Table 56. Global Tourette Syndrome Drug Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Tourette Syndrome Drug Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Tourette Syndrome Drug Sales Market Share in Value by Application (2024-2034)
Table 59. Global Tourette Syndrome Drug Price by Application (2024-2034) & (USD/Pcs)
Table 60. North America Tourette Syndrome Drug Sales by Application (2018-2024) (K Pcs)
Table 61. North America Tourette Syndrome Drug Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe Tourette Syndrome Drug Sales by Application (2018-2024) (K Pcs)
Table 63. Europe Tourette Syndrome Drug Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific Tourette Syndrome Drug Sales by Application (2018-2024) (K Pcs)
Table 65. Asia-Pacific Tourette Syndrome Drug Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America Tourette Syndrome Drug Sales by Application (2018-2024) (K Pcs)
Table 67. Latin America Tourette Syndrome Drug Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa Tourette Syndrome Drug Sales by Application (2018-2024) (K Pcs)
Table 69. Middle East and Africa Tourette Syndrome Drug Sales by Application (2018-2024) & (US$ Million)
Table 70. North America Tourette Syndrome Drug Sales by Country (2018-2024) & (K Pcs)
Table 71. North America Tourette Syndrome Drug Sales Market Share in Volume by Country (2018-2024)
Table 72. North America Tourette Syndrome Drug Sales by Country (2018-2024) & (US$ Million)
Table 73. North America Tourette Syndrome Drug Sales Market Share in Value by Country (2018-2024)
Table 74. North America Tourette Syndrome Drug Sales by Country (2024-2034) & (K Pcs)
Table 75. North America Tourette Syndrome Drug Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Tourette Syndrome Drug Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Tourette Syndrome Drug Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Tourette Syndrome Drug Sales by Country (2018-2024) & (K Pcs)
Table 79. Europe Tourette Syndrome Drug Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe Tourette Syndrome Drug Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe Tourette Syndrome Drug Sales Market Share in Value by Country (2018-2024)
Table 82. Europe Tourette Syndrome Drug Sales by Country (2024-2034) & (K Pcs)
Table 83. Europe Tourette Syndrome Drug Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Tourette Syndrome Drug Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Tourette Syndrome Drug Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Tourette Syndrome Drug Sales by Region (2018-2024) & (K Pcs)
Table 87. Asia-Pacific Tourette Syndrome Drug Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific Tourette Syndrome Drug Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific Tourette Syndrome Drug Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific Tourette Syndrome Drug Sales by Region (2024-2034) & (K Pcs)
Table 91. Asia-Pacific Tourette Syndrome Drug Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Tourette Syndrome Drug Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Tourette Syndrome Drug Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Tourette Syndrome Drug Sales by Country (2018-2024) & (K Pcs)
Table 95. Latin America Tourette Syndrome Drug Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America Tourette Syndrome Drug Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America Tourette Syndrome Drug Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America Tourette Syndrome Drug Sales by Country (2024-2034) & (K Pcs)
Table 99. Latin America Tourette Syndrome Drug Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Tourette Syndrome Drug Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Tourette Syndrome Drug Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Tourette Syndrome Drug Sales by Country (2018-2024) & (K Pcs)
Table 103. Middle East and Africa Tourette Syndrome Drug Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa Tourette Syndrome Drug Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa Tourette Syndrome Drug Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa Tourette Syndrome Drug Sales by Country (2024-2034) & (K Pcs)
Table 107. Middle East and Africa Tourette Syndrome Drug Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Tourette Syndrome Drug Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Tourette Syndrome Drug Sales Market Share in Value by Country (2024-2034)
Table 110. Abide Therapeutics Inc Company Information
Table 111. Abide Therapeutics Inc Introduction and Business Overview
Table 112. Abide Therapeutics Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 113. Abide Therapeutics Inc Tourette Syndrome Drug Product
Table 114. Abide Therapeutics Inc Recent Development
Table 115. Catalyst Pharmaceuticals Inc Company Information
Table 116. Catalyst Pharmaceuticals Inc Introduction and Business Overview
Table 117. Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 118. Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Product
Table 119. Catalyst Pharmaceuticals Inc Recent Development
Table 120. Neurocrine Biosciences Inc Company Information
Table 121. Neurocrine Biosciences Inc Introduction and Business Overview
Table 122. Neurocrine Biosciences Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 123. Neurocrine Biosciences Inc Tourette Syndrome Drug Product
Table 124. Neurocrine Biosciences Inc Recent Development
Table 125. Psyadon Pharmaceuticals Inc Company Information
Table 126. Psyadon Pharmaceuticals Inc Introduction and Business Overview
Table 127. Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 128. Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Product
Table 129. Psyadon Pharmaceuticals Inc Recent Development
Table 130. Reviva Pharmaceuticals Inc Company Information
Table 131. Reviva Pharmaceuticals Inc Introduction and Business Overview
Table 132. Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 133. Reviva Pharmaceuticals Inc Tourette Syndrome Drug Product
Table 134. Reviva Pharmaceuticals Inc Recent Development
Table 135. Synchroneuron Inc Company Information
Table 136. Synchroneuron Inc Introduction and Business Overview
Table 137. Synchroneuron Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 138. Synchroneuron Inc Tourette Syndrome Drug Product
Table 139. Synchroneuron Inc Recent Development
Table 140. Teva Pharmaceutical Industries Ltd Company Information
Table 141. Teva Pharmaceutical Industries Ltd Introduction and Business Overview
Table 142. Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 143. Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Product
Table 144. Teva Pharmaceutical Industries Ltd Recent Development
Table 145. Therapix Biosciences Ltd Company Information
Table 146. Therapix Biosciences Ltd Introduction and Business Overview
Table 147. Therapix Biosciences Ltd Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 148. Therapix Biosciences Ltd Tourette Syndrome Drug Product
Table 149. Therapix Biosciences Ltd Recent Development
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Tourette Syndrome Drug Market Trends
Table 153. Tourette Syndrome Drug Market Drivers
Table 154. Tourette Syndrome Drug Market Challenges
Table 155. Tourette Syndrome Drug Market Restraints
Table 156. Tourette Syndrome Drug Distributors List
Table 157. Tourette Syndrome Drug Downstream Customers
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Tourette Syndrome Drug Product Picture
Figure 2. Global Tourette Syndrome Drug Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Tourette Syndrome Drug Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Tourette Syndrome Drug Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of AZD-5213
Figure 6. Global AZD-5213 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of CPP-115
Figure 8. Global CPP-115 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of Dutetrabenazine ER
Figure 10. Global Dutetrabenazine ER Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of Ecopipam Hydrochloride
Figure 12. Global Ecopipam Hydrochloride Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Product Picture of Others
Figure 14. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 15. Global Tourette Syndrome Drug Sales by Type (2018-2034) & (US$ Million)
Figure 16. Global Tourette Syndrome Drug Sales Market Share by Type in 2022 & 2034
Figure 17. North America Tourette Syndrome Drug Sales Market Share in Volume by Type in 2022
Figure 18. North America Tourette Syndrome Drug Sales Market Share in Value by Type in 2022
Figure 19. Europe Tourette Syndrome Drug Sales Market Share in Volume by Type in 2022
Figure 20. Europe Tourette Syndrome Drug Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Tourette Syndrome Drug Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Tourette Syndrome Drug Sales Market Share in Value by Type in 2022
Figure 23. Latin America Tourette Syndrome Drug Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Tourette Syndrome Drug Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Tourette Syndrome Drug Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Tourette Syndrome Drug Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Tourette Syndrome Drug Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Tourette Syndrome Drug Revenue in 2022
Figure 29. Tourette Syndrome Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Research Center
Figure 31. Global Research Center Sales YoY Growth (2018-2034) & (K Pcs)
Figure 32. Product Picture of Hospital
Figure 33. Global Hospital Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Product Picture of Clinic
Figure 35. Global Clinic Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Product Picture of Others
Figure 37. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 38. Global Tourette Syndrome Drug Sales by Application (2018-2034) & (US$ Million)
Figure 39. Global Tourette Syndrome Drug Sales Market Share by Application in 2022 & 2034
Figure 40. North America Tourette Syndrome Drug Sales Market Share in Volume by Application in 2022
Figure 41. North America Tourette Syndrome Drug Sales Market Share in Value by Application in 2022
Figure 42. Europe Tourette Syndrome Drug Sales Market Share in Volume by Application in 2022
Figure 43. Europe Tourette Syndrome Drug Sales Market Share in Value by Application in 2022
Figure 44. Asia-Pacific Tourette Syndrome Drug Sales Market Share in Volume by Application in 2022
Figure 45. Asia-Pacific Tourette Syndrome Drug Sales Market Share in Value by Application in 2022
Figure 46. Latin America Tourette Syndrome Drug Sales Market Share in Volume by Application in 2022
Figure 47. Latin America Tourette Syndrome Drug Sales Market Share in Value by Application in 2022
Figure 48. Middle East and Africa Tourette Syndrome Drug Sales Market Share in Value by Application in 2022
Figure 49. Key Raw Materials Price
Figure 50. Tourette Syndrome Drug Manufacturing Cost Structure
Figure 51. Tourette Syndrome Drug Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries